EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

Clinical Implementation of Nephrologist-Led Genomic Testing for Glomerular Diseases in Singapore: Rationale and Protocol

Cynthia Lim, Ru Sin Lim, Jason Choo, Esther Huimin Leow, Gek Cher Chan, Yaochun Zhang, Jun Li Ng, Hui-Lin Chin, Ee Shien Tan, Jeannette Goh, Naline Gandhi, Yong Hong Ng und 20 weitere

American Journal of Nephrology · 2024

DOI: 10.1159/000542942 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift American Journal of Nephrology, 2024. Verfasst von Cynthia Lim und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Medicine, Singapore General Hospital, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore. Hauptthemen laut MEDLINE: Genetic Testing, Nephrologists, Nephrology. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The early diagnosis and appropriate treatment of monogenic glomerular diseases can reduce kidney failure, avoid unnecessary investigations such as kidney biopsies and ineffective treatment with immunosuppressants, guide transplant decisions, and inform the genetic risks of their family members. Yet, genetic testing for kidney disease is underutilized in Singapore. We aimed to implement a nephrologist-led genetic service and evaluate the acceptance, adoption, utility, and cost-effectiveness of genetic testing for monogenic glomerular disease in Singapore.

Methods

We will perform a prospective, multi-centre, type II hybrid effectiveness-implementation study with a post-design to evaluate both implementation and clinical outcomes of nephrologist-led genetic testing for suspected genetic glomerular kidney diseases. The multi-disciplinary implementation team will train “genetic nephrologists” to provide pre- and post-test counselling, order targeted exome panel sequencing for suspected glomerular kidney diseases (persistent microscopic haematuria and/or albuminuria or proteinuria in the absence of known causes, steroid-resistant primary nephrotic syndrome, apparent familial IgA nephropathy, or chronic kidney disease with no apparent cause), and interpret genetic test results; create workflows for patient referral, evaluation and management, and discuss genetic results at regular genomic board meetings. The outcomes are acceptance, appropriateness and adoption among patients and nephrologists, utility (proportion of patients who received genetic testing and have a confirmed diagnosis of genetic glomerular disease), and cost-effectiveness.

Conclusion

This study will create and evaluate a nephrologist-led genetic service, develop an efficient variant curation process, and inform future recommendations on the optimal referral and genetic testing strategy for monogenic glomerular disease in Singapore. This will facilitate the future mainstreaming of genetic testing that will enable precision medicine in kidney care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingNephrologistsNephrologyHumansSingaporeProspective StudiesCost-Benefit AnalysisMulticenter Studies as Topic

Stichwörter der Autor:innen

Genomic testGlomerulonephritisImplementation scienceRare kidney disease

Autor:innen und Institutionen

  • Department of Renal Medicine, Medicine, Singapore General Hospital, SingHealth Duke-NUS Academic Medical Center, Singapore, Singapore.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Department of Renal Medicine, Tan Tock Seng Hospital, Singapore, Singapore.
  • Department of Paediatrics, Nephrology, KK Women's and Children's Hospital, Singapore, Singapore.
  • Department of Medicine, Nephrology, National University Hospital, Singapore, Singapore.
  • Department of Paediatrics, National University of Singapore, Singapore, Singapore.

Zitieren

APA

Lim, C., Lim, R. S., Choo, J., Leow, E. H., Chan, G. C., Zhang, Y., Ng, J. L., Chin, H. L., Tan, E. S., Goh, J., Gandhi, N., Ng, Y. H., Than, M., Ganesan, I., Chong, S. L., Yap, C., Chao, S. M., Cham, B., Kam, S., …, & Ng, K. H. (2024). Clinical Implementation of Nephrologist-Led Genomic Testing for Glomerular Diseases in Singapore: Rationale and Protocol. American Journal of Nephrology. https://doi.org/10.1159/000542942

Vancouver

Lim C, Lim RS, Choo J, Leow EH, Chan GC, Zhang Y, et al. Clinical Implementation of Nephrologist-Led Genomic Testing for Glomerular Diseases in Singapore: Rationale and Protocol. American Journal of Nephrology. 2024. doi:10.1159/000542942

BibTeX
@article{Lim2024,
  author = {Lim, Cynthia and Lim, Ru Sin and Choo, Jason and Leow, Esther Huimin and Chan, Gek Cher and Zhang, Yaochun and Ng, Jun Li and Chin, Hui-Lin and Tan, Ee Shien and Goh, Jeannette and Gandhi, Naline and Ng, Yong Hong and Than, Mya and Ganesan, Indra and Chong, Siew Le and Yap, Celeste and Chao, Sing Ming and Cham, Breana and Kam, Sylvia and Lim, Jiin Ying and Mok, Irene and Tan, Hui Zhuan and Kwek, Jia Liang and Lee, Tung Lin and Wang, Ziyin and Goh, Su Mein and Lim, Regina and Yeo, See Cheng and Teo, Boon Wee and Da, Yi and Matchar, David and Ng, Kar Hui},
  title = {Clinical Implementation of Nephrologist-Led Genomic Testing for Glomerular Diseases in Singapore: Rationale and Protocol},
  journal = {American Journal of Nephrology},
  year = {2024},
  doi = {10.1159/000542942}
}
Kostenlos starten →